![Rahul Kakkar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rahul Kakkar
Directeur Général chez
Pandion Operations, Inc.
Profil
Rahul Kakkar was the founder of Corvidia Therapeutics, Inc., founded in 2015, where the title held was Chief Medical & Strategy Officer from 2018 to 2019.
Current jobs include CEO-Partner at Flagship Pioneering, Inc. starting in 2025; Chief Executive Officer & Director at Pandion Operations, Inc. starting in 2019; President & Chief Executive Officer at Quotient Therapeutics Ltd. starting in 2025; and Independent Director at Attralus, Inc. starting in 2021.
Former jobs include President, Chief Executive Officer & Director at Tome Biosciences, Inc. from 2021 to 2024; Chief Executive Officer & Director at Pandion Therapeutics, Inc. from 2019 to 2021; Director-Emerging Innovations at AstraZeneca PLC from 2012 to 2016; and Entrepreneur-Partner at Polaris Growth Management LLC from 2021 to 2024.
Education includes an undergraduate degree from Tufts University conferred in 1997 and a doctorate from Tufts University School of Medicine conferred in 2002.
Postes actifs de Rahul Kakkar
| Sociétés | Poste | Début |
|---|---|---|
Pandion Operations, Inc.
 Pandion Operations, Inc. Miscellaneous Commercial ServicesCommercial Services Develops drugs for autoimmune, inflammatory and transplant indications | Directeur Général | 17/07/2019 |
Attralus, Inc.
 Attralus, Inc. Pharmaceuticals: MajorHealth Technology Develops novel pan-amyloid removal therapeutics | Directeur/Membre du Conseil | 10/05/2021 |
Flagship Pioneering, Inc.
 Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Private Equity Investor | 01/04/2025 |
Anciens postes connus de Rahul Kakkar
| Sociétés | Poste | Fin |
|---|---|---|
Polaris Growth Management LLC
 Polaris Growth Management LLC Investment ManagersFinance Polaris Partners invests primarily in companies in the consumer technology, digital media/entertainment, e-Commerce, network hardware, software and semiconductors sectors. They invest in seed, early-stage and high growth, middle-market companies. The firm's early-stage investments focus on information technology and life sciences companies. Within the information technology sector, Polaris looks for companies that are developing Internet and broadband infrastructure, enterprise software products, e-Commerce products/services, digital media/entertainment, consumer software, network hardware and network software. In the life sciences sector, the firm looks for companies that are developing medical devices, pharmaceuticals, genomics, proteomics, drug delivery, medical services and consumer products and services. Polaris' private equity efforts focus on high-growth, middle-market companies in industries including technology, healthcare, digital media, consumer products and services and business services. Polaris serves as the lead or co-lead investor in the vast majority of their portfolio companies. The firm participates in minority growth equity investments, recapitalizations with liquidity and LBOs. | Private Equity Investor | 01/12/2024 |
Tome Biosciences, Inc.
 Tome Biosciences, Inc. BiotechnologyHealth Technology Provides genomic medicine insertion and technologies services | Directeur Général | 01/10/2024 |
| PANDION THERAPEUTICS, INC. | Directeur Général | 01/04/2021 |
Corvidia Therapeutics, Inc.
 Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Develops precision cardiovascular therapies | Fondateur | 01/05/2019 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/01/2016 |
Formation de Rahul Kakkar
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
57
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Polaris Growth Management LLC
Polaris Growth Management LLC Investment ManagersFinance Polaris Partners invests primarily in companies in the consumer technology, digital media/entertainment, e-Commerce, network hardware, software and semiconductors sectors. They invest in seed, early-stage and high growth, middle-market companies. The firm's early-stage investments focus on information technology and life sciences companies. Within the information technology sector, Polaris looks for companies that are developing Internet and broadband infrastructure, enterprise software products, e-Commerce products/services, digital media/entertainment, consumer software, network hardware and network software. In the life sciences sector, the firm looks for companies that are developing medical devices, pharmaceuticals, genomics, proteomics, drug delivery, medical services and consumer products and services. Polaris' private equity efforts focus on high-growth, middle-market companies in industries including technology, healthcare, digital media, consumer products and services and business services. Polaris serves as the lead or co-lead investor in the vast majority of their portfolio companies. The firm participates in minority growth equity investments, recapitalizations with liquidity and LBOs. | Finance |
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Finance |
Tufts University
 Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tufts University School of Medicine
 Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Corvidia Therapeutics, Inc.
Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Develops precision cardiovascular therapies | Health Technology |
Pandion Operations, Inc.
Pandion Operations, Inc. Miscellaneous Commercial ServicesCommercial Services Develops drugs for autoimmune, inflammatory and transplant indications | Commercial Services |
Pandion Therapeutics, Inc.
 Pandion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company which develops novel therapeutics for autoimmune diseases | Health Technology |
Attralus, Inc.
Attralus, Inc. Pharmaceuticals: MajorHealth Technology Develops novel pan-amyloid removal therapeutics | Health Technology |
Tome Biosciences, Inc.
Tome Biosciences, Inc. BiotechnologyHealth Technology Provides genomic medicine insertion and technologies services | Health Technology |
Choisissez Zonebourse 
